SAFC Pharma Completes $12M Expansion to Manufacturing Facility
SAFC Pharma, a business segment of SAFC®, a member of the Sigma-Aldrich® Group (NASDAQ: SIAL), announced the completion of a $12M expansion to its Carlsbad, Calif. manufacturing facility, which will scale-up its commercial output capacity for viral vaccines, biologics and sophisticated gene therapy solutions. The new facility expansion includes two stand-alone suites utilizing the latest in disposable bioreactors, streamlining production workflows and reducing the overall drug development window for its clients. This facility will specialize in developing and manufacturing viral therapeutics and vaccines. Designed specifically for multi-lot campaigns and offering cleanroom, bioreactor production, purification and dedicated cell expansion, this 18%…